Hims offers Apotex's generic semaglutide in Canada after Novo patent expiry - Reuters

Reuters | May 21, 2026, 1:13 p.m. | Original
Hims offers Apotex's generic semaglutide in Canada after Novo patent expiry Reuters
Exclusive: Modal Labs valued at $4.65 billion as AI coding takes off - Reuters US Treasuries selloff exacerbated as mortgage investors hedge against rising yields - Reuters